NCT04898491 Validity and Reliability Study of the Pain Indicator Behavior Scale-Brain Damage (ESCID-DC)
| NCT ID | NCT04898491 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Candelas Lopez Lopez |
| Condition | Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2022-06-01 |
| Primary Completion | 2023-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2022-06-01 with a primary completion date of 2023-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A multicentre observational study to validate the adaptation of the Pain Indicator Behavior Scale (ESCID) for patients with acquired Brain Damage (ESCID-DC), as a measuring instrument.
Eligibility Criteria
Inclusion Criteria: 1. Age equal to or greater than 18 years. 2. Inability to communicate verbally or motor. 3. Have a artificial airway. 4. Informed consent of the family member or representative of the patient. Exclusion Criteria: 1. Previous pathology of cognitive impairment. 2. Previous brain injury. 3. Previous psychiatric disorder. 4. Previous dementia. 5. Previous chronic substance abuse. 6. Previous chronic diabetics. 7. Previous spinal cord injury. 8. Previous severe polyneuropathy (diagnosed or suspected). 9. Confirmed diagnosis of brain death. 10. Continuous infusion of muscle relaxants and / or barbiturate coma. 11. Level of deep sedation (RASS -5).
Contact & Investigator
Candelas López-López, PhD
STUDY CHAIR
Emergency and Trauma Intensive Care Unit. Hospital Universitario 12 de Octubre
Frequently Asked Questions
Who can join the NCT04898491 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04898491 currently recruiting?
Yes, NCT04898491 is actively recruiting participants. Contact the research team at candelas.lopez@salud.madrid.org for enrollment information.
Where is the NCT04898491 trial being conducted?
This trial is being conducted at Madrid, Spain.
Who is sponsoring the NCT04898491 clinical trial?
NCT04898491 is sponsored by Candelas Lopez Lopez. The principal investigator is Candelas López-López, PhD at Emergency and Trauma Intensive Care Unit. Hospital Universitario 12 de Octubre. The trial plans to enroll 300 participants.